Speedel Pharma AG
7 articles about Speedel Pharma AG
-
Speedel Pharma AG Appoints New Head of Communications and Investor Relations
4/21/2008
-
Speedel Group Release: SPP100 (Tekturna/Rasilex) Reduces Left Ventricular Hypertrophy
4/1/2008
-
Speedel Pharma AG Annual Report Published
3/20/2008
-
Speedel Pharmaceuticals, Inc. Announces Financial Results For Full Year 2006
3/29/2007
-
Speedel Stops Current SPP301 Phase III Trial In Diabetic Kidney Disease In The Interests Of Patient Safety
12/19/2006
-
Speedel Group Release: SPP301 Phase IIb Results In Diabetic Nephropathy Presented At ASN
11/14/2005
-
Speedel Mulls IPO, Other Options, To Raise Cash For Phase III Trial
7/8/2005